{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:37:02Z","timestamp":1790681822893,"version":"4.1.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.ctrv.2011.07.006","type":"journal-article","created":{"date-parts":[[2011,8,19]],"date-time":"2011-08-19T02:23:02Z","timestamp":1313720582000},"page":"379-386","source":"Crossref","is-referenced-by-count":100,"title":["Electrochemotherapy of chest wall breast cancer recurrence"],"prefix":"10.1016","volume":"38","author":[{"given":"Gregor","family":"Sersa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Cufer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snezna Marija","family":"Paulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Cemazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Snoj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctrv.2011.07.006_b0005","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1529-8019.2010.01365.x","article-title":"Cutaneous manifestations of breast carcinoma","volume":"23","author":"De Giorgi","year":"2010","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ctrv.2011.07.006_b0010","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJM199710023371401","article-title":"Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial","volume":"337","author":"Overgaard","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctrv.2011.07.006_b0015","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1200\/JCO.2005.02.8738","article-title":"Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies","volume":"24","author":"Nielsen","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2011.07.006_b0020","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/jnci\/djh297","article-title":"Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial","volume":"97","author":"Ragaz","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ctrv.2011.07.006_b0025","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.suc.2007.01.011","article-title":"Postmastectomy radiation therapy: indications and controversies","volume":"87","author":"Lee","year":"2007","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.ctrv.2011.07.006_b0030","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1245\/s10434-009-0662-7","article-title":"Prognostic factors in 77 curative chest wall resections for isolated breast cancer recurrence","volume":"16","author":"van der Pol","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctrv.2011.07.006_b0035","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1245\/ASO.2003.01.004","article-title":"Chest wall recurrence after mastectomy does not always portend a dismal outcome","volume":"10","author":"Chagpar","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctrv.2011.07.006_b0040","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.athoracsur.2010.06.044","article-title":"Sternal resection for sarcoma, recurrent breast cancer, and radiation-induced necrosis","volume":"90","author":"Koppert","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ctrv.2011.07.006_b0045","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.semradonc.2009.05.009","article-title":"Postmastectomy radiation therapy for patients with locally advanced breast cancer","volume":"19","author":"Jagsi","year":"2009","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ctrv.2011.07.006_b0050","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.radonc.2010.10.020","article-title":"Durable palliation of breast cancer chest wall recurrence with radiation therapy, hyperthermia, and chemotherapy","volume":"97","author":"Zagar","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctrv.2011.07.006_b0055","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1200\/JCO.2001.19.21.4150","article-title":"Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer","volume":"21","author":"Leonard","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2011.07.006_b0060","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1002\/1097-0142(19931215)72:12<3694::AID-CNCR2820721222>3.0.CO;2-2","article-title":"Electrochemotherapy, a new antitumor treatment. First clinical phase I\u2013II trial","volume":"72","author":"Belehradek","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2011.07.006_b0065","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1038\/bjc.1998.388","article-title":"Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy","volume":"77","author":"Mir","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ctrv.2011.07.006_b0070","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ejso.2007.05.016","article-title":"Electrochemotherapy in treatment of tumours","volume":"34","author":"Sersa","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ctrv.2011.07.006_b0075","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1586\/era.09.129","article-title":"Electrochemotherapy as an adjunct or alternative to other treatments for unresectable or in-transit melanoma","volume":"9","author":"Moller","year":"2009","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.ctrv.2011.07.006_b0415","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/j.1460-2075.1982.tb01257.x","article-title":"Gene-transfer into mouse lyoma cells by electroporation in high electric-fields","volume":"1","author":"Neumann","year":"1982","journal-title":"EMBO J"},{"key":"10.1016\/j.ctrv.2011.07.006_b0085","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0169-409X(98)00066-0","article-title":"Mechanisms of electrochemotherapy","volume":"35","author":"Mir","year":"1999","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ctrv.2011.07.006_b0090","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00001813-199804000-00005","article-title":"Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs","volume":"9","author":"Gehl","year":"1998","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.ctrv.2011.07.006_b0095","first-page":"3450","article-title":"Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice","volume":"55","author":"Sersa","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctrv.2011.07.006_b0100","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00001813-200003000-00008","article-title":"Toxicity of anticancer agents mediated by electroporation in vitro","volume":"11","author":"Jaroszeski","year":"2000","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.ctrv.2011.07.006_b0105","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2478\/v10019-009-0037-5","article-title":"Enhanced cytotoxicity of bleomycin and cisplatin after electroporation in murine colorectal carcinoma cells","volume":"43","author":"Todorovic","year":"2009","journal-title":"Radiol Oncol"},{"key":"10.1016\/j.ctrv.2011.07.006_b0110","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/sj.bjc.6690222","article-title":"Increased platinum accumulation in SA-1 tumour cells after in vivo electrochemotherapy with cisplatin","volume":"79","author":"Cemazar","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ctrv.2011.07.006_b0115","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1939-1676.2008.0117.x","article-title":"Electrochemotherapy in veterinary oncology","volume":"22","author":"Cemazar","year":"2008","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.ctrv.2011.07.006_b0120","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2478\/v10019-010-0002-3","article-title":"Numerical study of the electroporation pulse shape effect on molecular uptake of biological cells","volume":"44","author":"Miklavcic","year":"2010","journal-title":"Radiol Oncol"},{"key":"10.1016\/j.ctrv.2011.07.006_b0125","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2478\/v10019-008-0005-5","article-title":"Optimization of electrode position and electric pulse amplitude in electrochemotherapy","volume":"42","author":"Zupanic","year":"2008","journal-title":"Radiol Oncol"},{"key":"10.1016\/j.ctrv.2011.07.006_b0130","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1586\/era.10.43","article-title":"Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases","volume":"10","author":"Jarm","year":"2010","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.ctrv.2011.07.006_b0135","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0959-8049(98)00426-2","article-title":"Tumour blood flow changes induced by application of electric pulses","volume":"35","author":"Sersa","year":"1999","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ctrv.2011.07.006_b0140","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1054\/bjoc.2000.1625","article-title":"Electroporation of human microvascular endothelial cells: evidence for an anti-vascular mechanism of electrochemotherapy","volume":"84","author":"Cemazar","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ctrv.2011.07.006_b0145","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/sj.bjc.6604168","article-title":"Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma","volume":"98","author":"Sersa","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ctrv.2011.07.006_b0150","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00002371-199501000-00004","article-title":"Systemic antitumor effects of electrochemotherapy combined with histoin compatible cells secreting interleukin-2","volume":"17","author":"Mir","year":"1995","journal-title":"J Immunother Emphasis Tumor Immunol"},{"key":"10.1016\/j.ctrv.2011.07.006_b0155","first-page":"297","article-title":"Electrochemotherapy with CDDP on LPB sarcoma: comparison of the anti-tumor effectiveness in immunocompetent and immunodeficient mice","volume":"43","author":"Sersa","year":"1997","journal-title":"Bioelectrochem Bioenergy"},{"key":"10.1016\/j.ctrv.2011.07.006_b0160","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejcsup.2006.08.006","article-title":"Importance of tumour coverage by sufficiently high local electric field for effective electrochemotherapy","volume":"4","author":"Miklavcic","year":"2006","journal-title":"EJC Suppl"},{"key":"10.1016\/j.ctrv.2011.07.006_b0165","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejcsup.2006.08.003","article-title":"Standard operating procedures of the electrochemotherapy: instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the cliniporator (TM) by means of invasive or non-invasive electrodes","volume":"4","author":"Mir","year":"2006","journal-title":"EJC Suppl"},{"key":"10.1016\/j.ctrv.2011.07.006_b0170","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1529-8019.2010.01370.x","article-title":"Electrochemotherapy for cutaneous and subcutaneous tumor lesions: a novel therapeutic approach","volume":"23","author":"Testori","year":"2010","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ctrv.2011.07.006_b0175","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bioelechem.2004.04.001","article-title":"Techniques of signal generation required for electropermeabilization. Survey of electropermeabilization devices","volume":"64","author":"Puc","year":"2004","journal-title":"Bioelectrochemistry"},{"key":"10.1016\/j.ctrv.2011.07.006_b0180","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1475-925X-9-10","article-title":"Towards treatment planning and treatment of deep-seated solid tumors by electrochemotherapy","volume":"9","author":"Miklavcic","year":"2010","journal-title":"Biomed Eng Online"},{"key":"10.1016\/j.ctrv.2011.07.006_b0185","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1046\/j.1365-201X.2003.01093.x","article-title":"Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research","volume":"177","author":"Gehl","year":"2003","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.ctrv.2011.07.006_b0190","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0305-7372(03)00073-2","article-title":"Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation","volume":"29","author":"Gothelf","year":"2003","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ctrv.2011.07.006_b0195","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0169-409X(98)00067-2","article-title":"Clinical applications of electrochemotherapy","volume":"26","author":"Heller","year":"1999","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ctrv.2011.07.006_b0200","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0302-4598(95)01823-W","article-title":"Biomedical applications of electric pulses with special emphasis on antitumor electrochemotherapy","volume":"38","author":"Mir","year":"1995","journal-title":"Bioelectrochem Bioenergy"},{"key":"10.1016\/j.ctrv.2011.07.006_b0205","first-page":"229","article-title":"Electrochemotherapy with bleomycin: the first clinical experience in malignant melanoma patients","volume":"29","author":"Rudolf","year":"1995","journal-title":"Radiol Oncol"},{"key":"10.1016\/j.ctrv.2011.07.006_b0210","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/(SICI)1097-0142(19960301)77:5<956::AID-CNCR23>3.0.CO;2-1","article-title":"Antitumor electrochemotherapy: new advances in the clinical protocol","volume":"77","author":"Domenge","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2011.07.006_b0215","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/archderm.1996.03890350095015","article-title":"Bleomycin-mediated electrochemotherapy of metastatic melanoma","volume":"132","author":"Glass","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ctrv.2011.07.006_b0220","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/(SICI)1097-0142(19960301)77:5<964::AID-CNCR24>3.0.CO;2-0","article-title":"Phase I\/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy","volume":"77","author":"Heller","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2011.07.006_b0225","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/(SICI)1097-0142(19980701)83:1<148::AID-CNCR20>3.0.CO;2-W","article-title":"Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin","volume":"83","author":"Heller","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2011.07.006_b0230","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/00008390-200010000-00009","article-title":"Electrochemotherapy of cutaneous metastases in malignant melanoma","volume":"10","author":"Rols","year":"2000","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ctrv.2011.07.006_b0235","first-page":"863","article-title":"Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients","volume":"6","author":"Sersa","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ctrv.2011.07.006_b0240","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00008390-200008000-00010","article-title":"Electrochemotherapy with cisplatin: the systemic antitumour effectiveness of cisplatin can be potentiated locally by the application of electric pulses in the treatment of malignant melanoma skin metastases","volume":"10","author":"Sersa","year":"2000","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ctrv.2011.07.006_b0245","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0188-4409(01)00278-8","article-title":"Electrochemotherapy in primary and metastatic skin tumors: phase II trial using intralesional bleomycin","volume":"32","author":"Rodriguez-Cuevas","year":"2001","journal-title":"Arch Med Res"},{"key":"10.1016\/j.ctrv.2011.07.006_b0250","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00008390-200502000-00008","article-title":"Treatment of metastatic melanoma using electroporation therapy with bleomycin (electrochemotherapy)","volume":"15","author":"Byrne","year":"2005","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ctrv.2011.07.006_b0255","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/01.sla.0000250419.36053.33","article-title":"Electrochemotherapy \u2013 aspects of preclinical development and early clinical experience","volume":"245","author":"Larkin","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.ctrv.2011.07.006_b0260","first-page":"391","article-title":"Effective treatment of multiple unresectable skin melanoma metastases by electrochemotherapy","volume":"48","author":"Snoj","year":"2007","journal-title":"Croat Med J"},{"key":"10.1016\/j.ctrv.2011.07.006_b0265","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1245\/s10434-008-9976-0","article-title":"Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases","volume":"15","author":"Quaglino","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctrv.2011.07.006_b0270","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1245\/s10434-008-0204-8","article-title":"Bleomycin-based electrochemotherapy: clinical outcome from a single institution\u2019s experience with 52 patients","volume":"16","author":"Campana","year":"2009","journal-title":"Annal Surg Oncol"},{"key":"10.1016\/j.ctrv.2011.07.006_b0275","first-page":"613","article-title":"Electrochemotherapy, a new antitumor treatment: first clinical trial","volume":"313","author":"Mir","year":"1991","journal-title":"C R Acad Sci III"},{"key":"10.1016\/j.ctrv.2011.07.006_b0280","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0190-9622(97)70178-6","article-title":"Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma","volume":"37","author":"Glass","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ctrv.2011.07.006_b0285","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1177\/000348949810700908","article-title":"Electroporation therapy of head and neck cancer","volume":"107","author":"Panje","year":"1998","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.ctrv.2011.07.006_b0290","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/030089160008600211","article-title":"Electrochemotherapy with bleomycin in the treatment of hypernephroma metastasis: case report and literature review","volume":"86","author":"Sersa","year":"2000","journal-title":"Tumori"},{"key":"10.1016\/j.ctrv.2011.07.006_b0295","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00005537-200101000-00010","article-title":"Electroporation therapy for head and neck cancer including carotid artery involvement","volume":"111","author":"Allegretti","year":"2001","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ctrv.2011.07.006_b0300","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/00016480310001114","article-title":"Electroporation therapy in head and neck cancer","volume":"123","author":"Burian","year":"2003","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.ctrv.2011.07.006_b0305","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.cad.0000132234.30674.df","article-title":"Electrochemotherapy with cisplatin of cutaneous tumor lesions in breast cancer","volume":"15","author":"Rebersek","year":"2004","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.ctrv.2011.07.006_b0310","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.ejso.2005.04.007","article-title":"The role of intratumour therapy with electroporation and bleomycin in the management of advanced squamous cell carcinoma of the head and neck","volume":"31","author":"Bloom","year":"2005","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ctrv.2011.07.006_b0420","first-page":"S24","article-title":"Clinical, histological end immuno-histochemical negativisation of Kaposi skin nodule HHV 8 related after electrochemotherapy","author":"Gualdi","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ctrv.2011.07.006_b0320","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1524-4725.2008.34157.x","article-title":"Successful treatment of penile Kaposi\u2019s sarcoma with electrochemotherapy","volume":"34","author":"Curatolo","year":"2008","journal-title":"Dermat Surg"},{"key":"10.1016\/j.ctrv.2011.07.006_b0325","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/archderm.144.9.1186","article-title":"Metastatic basal cell carcinoma with squamous differentiation \u2013 report of a case with response of cutaneous metastases to electrochemotherapy","volume":"144","author":"Fantini","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ctrv.2011.07.006_b0330","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1001\/archdermatol.2009.25","article-title":"Remission of extensive Merkel cell carcinoma after electrochemotherapy","volume":"145","author":"Curatolo","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ctrv.2011.07.006_b0335","first-page":"265","article-title":"Electrochemotherapy in cancer patients: first clinical trial in Greece","volume":"25","author":"Skarlatos","year":"2011","journal-title":"In Vivo"},{"key":"10.1016\/j.ctrv.2011.07.006_b0340","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejcsup.2006.08.002","article-title":"Electrochemotherapy \u2013 an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study","volume":"4","author":"Marty","year":"2006","journal-title":"EJC Suppl"},{"key":"10.1016\/j.ctrv.2011.07.006_b0345","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1177\/030089160909500324","article-title":"Limb sparing treatment of bleeding melanoma recurrence by electrochemotherapy","volume":"95","author":"Snoj","year":"2009","journal-title":"Tumori"},{"key":"10.1016\/j.ctrv.2011.07.006_b0350","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00001813-200503000-00015","article-title":"Successful sphincter-saving treatment of anorectal malignant melanoma with electrochemotherapy, local excision and adjuvant brachytherapy","volume":"16","author":"Snoj","year":"2005","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.ctrv.2011.07.006_b0355","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/00008390-200012000-00011","article-title":"Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy","volume":"10","author":"Gehl","year":"2000","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ctrv.2011.07.006_b0360","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejcsup.2006.07.007","article-title":"Palliation of haemorrhaging and ulcerated cutaneous tumours using electrochemotherapy","volume":"4","author":"Gehl","year":"2006","journal-title":"EJC Suppl"},{"key":"10.1016\/j.ctrv.2011.07.006_b0365","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejcsup.2006.08.007","article-title":"The state-of-the-art of electrochemotherapy before the ESOPE study; advantages and clinical uses","volume":"4","author":"Sersa","year":"2006","journal-title":"EJC Suppl"},{"issue":"Suppl. 6","key":"10.1016\/j.ctrv.2011.07.006_b0370","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/annonc\/mdp257","article-title":"Surgery and radiotherapy in the treatment of cutaneous melanoma","volume":"20","author":"Testori","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctrv.2011.07.006_b0375","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3109\/0284186X.2011.573626","article-title":"Management of cutaneous metastases using electrochemotherapy","volume":"50","author":"Matthiessen","year":"2011","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ctrv.2011.07.006_b0380","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejcsup.2006.07.006","article-title":"Effective treatment of an extensive recurrent breast cancer which was refractory to multimodal therapy by multiple applications of electrochemotherapy","volume":"4","author":"Whelan","year":"2006","journal-title":"EJC Suppl"},{"key":"10.1016\/j.ctrv.2011.07.006_b0385","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1359-6349(09)70933-4","article-title":"Electrochemotherapy as palliative treatment for chest wall recurrence of breast cancer \u2013 initial results","volume":"7","author":"Matthiessen","year":"2009","journal-title":"EJC Suppl"},{"key":"10.1016\/j.ctrv.2011.07.006_b0390","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejcsup.2008.06.062","article-title":"Electrochemotherapy (ECT) for the treatment of superficial tumour metastases","volume":"6","author":"Guida","year":"2008","journal-title":"EJC Suppl"},{"key":"10.1016\/j.ctrv.2011.07.006_b0395","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bioelechem.2004.07.004","article-title":"The effect of high frequency electric pulses on muscle contractions and antitumor efficiency in vivo for a potential use in clinical electrochemotherapy","volume":"65","author":"Miklavcic","year":"2005","journal-title":"Bioelectrochemistry"},{"key":"10.1016\/j.ctrv.2011.07.006_b0400","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00232-010-9268-z","article-title":"Electrochemotherapy of mouse sarcoma tumors using electric pulse trains with repetition frequencies of 1 Hz and 5 kHz","volume":"236","author":"Sersa","year":"2010","journal-title":"J Membr Biol"},{"key":"10.1016\/j.ctrv.2011.07.006_b0405","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s11517-008-0346-7","article-title":"The effect of electroporation pulses on functioning of the heart","volume":"46","author":"Mali","year":"2008","journal-title":"Med Biol Eng Comput"},{"key":"10.1016\/j.ctrv.2011.07.006_b0410","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2147\/TCRM.S2780","article-title":"Cost-effectiveness analysis of electrochemotherapy with the cliniporator trade mark vs. other methods for the control and treatment of cutaneous and subcutaneous tumors","volume":"4","author":"Colombo","year":"2008","journal-title":"Ther Clin Risk Manag"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737211001733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737211001733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T12:06:41Z","timestamp":1592827601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737211001733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":82,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0305737211001733"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2011.07.006","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}